Episode

How can we use AI to make drugs?

Podcast
Oxford Sparks Big Questions
Published
Jun 17, 2026
Duration seconds
728
Processing state
not_requested
Canonical source
https://oxfordsparks.libsyn.com/how-can-we-use-ai-to-make-drugs
Audio
https://traffic.libsyn.com/secure/oxfordsparks/Ox-AI_drugs-v1.mp3?dest-id=790107
JSON
/v1/public/podcasts/oxford-sparks-big-questions-420721/episodes/how-can-we-use-ai-to-make-drugs
Markdown
/podcast/oxford-sparks-big-questions-420721/how-can-we-use-ai-to-make-drugs.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/oxford-sparks-big-questions-420721/episodes/how-can-we-use-ai-to-make-drugs/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/oxford-sparks-big-questions-420721/how-can-we-use-ai-to-make-drugs.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Put simply, most drugs work by binding to a protein and altering how they function. But how can we model how well a particular molecule will bind to a particular protein, and use that knowledge to help discover new treatments? In this episode, we talk to Prof Fergus Imrie from Oxford's Department of Statistics, who is one of the lead researchers on the OpenBind consortium. This project aims to create the world's largest open-access dataset of protein-ligand interactions, providing invaluable quantities of data for AI-driven drug discovery